Takeda Return On Tangible Assets from 2010 to 2024
| TAK Stock | USD 13.37 0.01 0.07% |
Return On Tangible Assets | First Reported 2010-12-31 | Previous Quarter 0.0744 | Current Value 0.0876 | Quarterly Volatility 0.03821146 |
Check Takeda Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takeda main balance sheet or income statement drivers, such as Depreciation And Amortization of 867.8 B, Interest Expense of 204.9 B or Selling General Administrative of 760.9 B, as well as many exotic indicators such as Price To Sales Ratio of 0.92, Dividend Yield of 0.0775 or PTB Ratio of 0.59. Takeda financial statements analysis is a perfect complement when working with Takeda Pharmaceutical Valuation or Volatility modules.
Takeda | Return On Tangible Assets |
Latest Takeda Pharmaceutical's Return On Tangible Assets Growth Pattern
Below is the plot of the Return On Tangible Assets of Takeda Pharmaceutical Co over the last few years. It is a profitability metric that measures a company's ability to generate earnings from its tangible assets. Takeda Pharmaceutical's Return On Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takeda Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| Return On Tangible Assets | 10 Years Trend |
|
Return On Tangible Assets |
| Timeline |
Takeda Return On Tangible Assets Regression Statistics
| Arithmetic Mean | 0.05 | |
| Coefficient Of Variation | 76.86 | |
| Mean Deviation | 0.03 | |
| Median | 0.06 | |
| Standard Deviation | 0.04 | |
| Sample Variance | 0 | |
| Range | 0.1481 | |
| R-Value | 0.19 | |
| Mean Square Error | 0 | |
| R-Squared | 0.04 | |
| Significance | 0.49 | |
| Slope | 0 | |
| Total Sum of Squares | 0.02 |
Takeda Return On Tangible Assets History
About Takeda Pharmaceutical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Takeda Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Takeda Pharmaceutical investors use historical funamental indicators, such as Takeda Pharmaceutical's Return On Tangible Assets, to determine how well the company is positioned to perform in the future. Although Takeda Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Takeda Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Takeda Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Takeda Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Takeda Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.09 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Takeda Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Takeda Pharmaceutical's short interest history, or implied volatility extrapolated from Takeda Pharmaceutical options trading.
Currently Active Assets on Macroaxis
When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:Check out the analysis of Takeda Pharmaceutical Correlation against competitors. Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Takeda Stock analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Takeda Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 184 | Earnings Share 0.37 | Revenue Per Share 1.3 K | Quarterly Revenue Growth 0.013 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.